[ Price : $8.95]
FDA issues a guidance answering questions about the direct marking of medical devices under the unique device identification regul...[ Price : $8.95]
The Senate approves a House bill retaining FDA authority over battlefield drug and medical device decisions.[ Price : $8.95]
FDA approves Genentechs Gazyva (obinutuzumab) in combination with chemotherapy, followed by Gazyva alone in those who responded, f...[ Price : $8.95]
Federal Register notice: FDA announces a 1/10/2018 Bone, Reproductive and Urologic Drugs Advisory Committee meeting that will disc...[ Price : $8.95]
Federal Register notice: FDA announces that an initial decision of the administrative law judge (ALJ) is now the final agency deci...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance on Best Practices for Convening a GRAS Panel.[ Price : $8.95]
The Government Accountability Office says FDA has properly implemented the 2014 Sunscreen Innovation Act in the time frames set by...[ Price : $8.95]
FDA approves Genentechs Hemlibra for preventing or reducing the frequency of bleeding episodes in those with hemophilia A.